前沿论文｜CELL INTELLIGENCE

Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies.

PubMed 2025/10/24 发表Adv Sci (Weinh)Q1 · IF 14.1（JCR 2025）

Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1.

PubMed 2024/01/11 发表Int J CancerQ2 · IF 4.9（JCR 2025）

前沿论文 2